Format

Send to

Choose Destination
Expert Opin Biol Ther. 2013 Nov;13(11):1523-41. doi: 10.1517/14712598.2013.842972. Epub 2013 Oct 5.

Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies.

Author information

1
Stanford University School of Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Hagey Laboratory for Pediatric Regenerative Medicine , 257 Campus Drive West, Hagey Building GK106, Stanford, CA 94305 5148 , USA.

Abstract

INTRODUCTION:

Normal wound healing mechanisms can be overwhelmed in the setting of complex acute and chronic tissue injury. Biological therapies are designed to augment and/or restore the body's natural wound healing abilities. There are a variety of available and emerging technologies utilizing this approach that have demonstrated the ability to augment wound healing.

AREAS COVERED:

In this review, the clinical data on launched and emerging biological therapies for wound healing applications are summarized. The methodologies discussed include biological skin equivalents, growth factors/small molecules and stem cell-based therapies.

EXPERT OPINION:

While many products possess convincing clinical data demonstrating their efficacy in comparison to standard treatment options, more robust, controlled studies are needed to determine the relative value among established and emerging biological therapies. Future bioengineering and stem cell-based approaches are of particular interest due to the simultaneous correction of multiple deficiencies present in the nonhealing wound.

PMID:
24093722
DOI:
10.1517/14712598.2013.842972
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center